Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
DX-2400
print preview
bookmark
share with colleague
General Information
Company
Dyax Corp.
Description
Human mAb against matrix metalloproteinase 14 (MMP14)
Molecular Target
Matrix metalloproteinase 14 (MMP14)
Mechanism of Action
Matrix metalloproteinase inhibitor (MMPI)
Latest Stage of Development
Preclinical
Indication
Solid tumors
Partner
Kadmon Corp. LLC
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy